Embracing Collaborations to Drive Development of Rare Disease Therapies

Collaborations have become a critical aspect of the search for new treatments for rare diseases as drug companies, universities, research institutes, and patient groups are forging alliances to leverage their strengths. Outside this year’s J.P. Morgan Healthcare Conference, Global Genes will convene Rare in the Square in San Francisco’s Union Square to provide rare-disease focused companies and organizations a place to network at the heart of the week’s activities. We spoke to Michael Pistone, director of marketing, innovation & commercialization at Cincinnati Children’s Hospital Medical Center, about his hospital’s rare disease partnerships with drug companies, how the face of partnering in the rare disease space is evolving, and what he’s hoping for at this year’s Rare in the Square event.